| Report | Options implied | Actual move | Market was |
|---|---|---|---|
| March 31, 2026 | ±3.4% | -6.1% | under-priced |
| October 7, 2025 | ±1.7% | -3.9% | under-priced |
| June 26, 2025 | ±1.8% | +5.3% | under-priced |
| March 25, 2025 | ±1.8% | -0.1% | over-priced |
| October 1, 2024 | ±1.3% | +2.2% | under-priced |
| June 27, 2024 | ±2.2% | +4.3% | under-priced |
| March 26, 2024 | ±2.3% | +10.5% | under-priced |
| October 3, 2023 | ±1.8% | -8.5% | under-priced |
| Quarter | EPS (dil.) | Revenue | Net income |
|---|---|---|---|
| Q1 FY2026 | $3.77 | $1.9B | $1.0B |
| Q4 FY2025 | $0.84 | $1.9B | $216M |
| Q3 FY2025 | $0.84 | $1.7B | $228M |
| Q2 FY2025 | $0.65 | $1.7B | $176M |
McCormick & Company, Incorporated Non-VTG CS (MKC) reports in 62 days, with the next report estimated for August 14, 2026. Across the last 8 reports, options priced an average ±2.0% earnings move while the stock actually moved 5.1% on average — the market has tended to under-price MKC's earnings risk. Fundamentals into the print: EPS up 528.3% year-over-year, revenue up 16.7%. QuantLogix's live 5-factor engine currently reads MKC as a buy at 51/100.
Implied move is derived from at-the-money option pricing; actual moves are close-to-close on report days. Next-report dates are estimates until confirmed by the company. Educational market analysis, not investment advice. Browse all signal scorecards →